Subjective contrast sensitivity for the stationary and horizontally drifting vertical stripe patterns was measured in normal subjects and in patients with glaucoma, optic neuritis and optic atrophy. Contrast sensitivity was aslo determined objectively using an eye movement reflex (optokinetic nystagmus) recorded by means of electro-oculography. The contrast sensitivity for the drifting stripe patterns in normal subjects was characterized by a depression of sensitivity at the high spatial frequency and an increased contrast sensitivity at the low spatial frequency in comparison with the results of stationary stripe patterns. The measurement of contrast sensitivity for the horizontally drifting vertical stripe patterns was found to be more sensitive for detection of minor damage to the optic nerve than that for the stationary patterns. The results of the subjective contrast sensitivity and the objective one determined using an eye movement reflex showed a good correlation.

Keywords:
Contrast sensitivity, Drifting pattern, Glaucoma, Optic neuritis, Optic Atrophy, Optokinetic nystagmus
This content is only available via PDF.
© 1993 S. Karger AG, Basel
1993
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.